High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Strategy has made its first bitcoin purchase in two months, acquiring 4,603 BTC for $369.7 million at an average price of $80,318 per coin, according to a Monday morning press release from the company. The purchase lifts Strategy’s total holdings to 845,050 BTC and ends a buying pause. The mechanics ...
Investing.com - U.S. stock futures were little changed early Tuesday as investors remained cautious about the prospect of further Federal Reserve rate hikes and renewed fighting between the United States and Iran.
India’s electric two-wheeler maker Ather Energy Ltd. is beating global EV stocks this year, with analysts pointing to more gains on its growing market share.
September is historically the market’s weakest month. Joe Tigay breaks down the signals he’s tracking – low VIX, inflation shocks, overspending in AI – and the stocks he’s watching on pullbacks including names like Alphabet and Amazon.
WTI crude climbed above $90 a barrel following U.S. military strikes, stoking inflation and rate-hike concerns, today, Aug. 31, 2026.
By Stephen Culp and Niket Nishant NEW YORK, Aug 31 (Reuters) - U.S. stocks weakened on Monday with markets turning the page on a volatile month as a war-related price jump in crude revived inflation
Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M
Dell Technologies (DELL) is set to report Q2 results after-market hours on Tuesday, Sept. 1, with expectations running high following explosive growth in its AI infrastructure business.
Management attributed the latest quarter’s increased revenue to a higher volume of client contracts.
Michael Saylor’s MicroStrategy purchases Bitcoin for the first time after June 15-21.
MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the “MD Sass Concentrated Value Strategy.” The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 […]
In an interview with CNBC, Tom Lee said he now sees upside risk in September, despite mounting market concerns.
The company continues to benefit from higher cybersecurity priority as enterprises deploy AI.
Comparable sales surged past guidance as emerging tech categories more than doubled.
Strategy, the bitcoin accumulation firm founded by Michael Saylor, said it bought about $370 million worth of the digital currency last week, its first purchase since June. Strategy said it acquired 4,603 bitcoin at an average price of $80,318 using proceeds from the sale of company's common shares. Strategy had paused its bitcoin purchases and sold bitcoin in recent weeks.
Palo Alto Networks shares have surged near record highs on AI-driven security demand ahead of earnings, but a triple-digit P/E ratio leaves little room for disappointment.
Strategy Inc. resumed Bitcoin purchases after a 10-week pause, returning to its signature accumulation strategy after the crypto bear market pressured its shares, weakened confidence in the financing model and prompted a balance-sheet overhaul.
Broadcom Stock Is Set for Results. Wall Street Expects $29.4 Billion in Revenue.
SAIC (SAIC) delivered earnings and revenue surprises of +33.78% and +7.52%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
The new month, historically the worst for the stock market, hasn’t quite started yet but it’s already looking like being fraught with risk. The market is getting more confident that the Federal Reserve will hike interest rates on Sept. 16, even if Federal Reserve Chairman Kevin Warsh didn’t quite say as much in his Jackson Hole speech Friday. Oil prices aren’t helping, rising above $90 a barrel after the U.S. attacked Iran over the weekend.
Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
ONEOK is set to acquire Brazos Midstream’s Permian Midland Basin natural gas gathering and processing assets for $4.43 billion, expanding its footprint in prolific American oil hub.
Investing.com -- Jefferies initiated coverage of Braveheart Bio with a Buy rating and a $48 price target, implying roughly 75% upside from the stock’s prior closing price. The move comes after the company priced its initial public offering (IPO) at $18 per share earlier this month, raising $382.5 million in one of the largest biotech debuts of 2026.
Technology stocks face a test from the prospect of higher interest rates after Fed Chairman Kevin Warsh issued a warning about inflation.
Investing.com - U.S. stock futures fell early Monday as renewed U.S.-Iran fighting pushed oil prices higher and added another layer of uncertainty for investors.
Stocks beat inflation 16 of 20 years, but faced above-4% CPI just three times. AI earnings now carry real returns.
Marvell shares fell despite strong fiscal Q2 results.
SK Hynix Inc. is studying the feasibility of a joint venture to make memory chips in Japan, one of several options under consideration to meet surging AI demand while controlling production costs.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
